BIOTECHNOLOGY AMGEN COMPANY

Running head: BIOTECHNOLOGY
AMGEN COMPANY
Name of the Student:
Name of the University:
Author Note:

AMGEN COMPANY1
Amgen – Summary1
Amgen is the largest multinational pharmaceutical company in America. This
organization provide numerous products related to biotechnology, and the business is based
on recombinant DNA technologies (Amgen Inc, 2020). This organization also comes in the
top position for any innovation in the field of biotechnology and thus, the organization focus
on the IP protection which includes the patent, trademark, copyright along with the trade
secrets. Thus, it is an additional benefit for the investors. As the organization is very
particular about the protection of their IP, and it would assist in filing any infringement cases.
Investors always look for security and IP protection; hence, investors can trust and invest in
the Amgen. Another reason for investment in Amgen is the reputation and recognition it has
built over the years (Amgen, 2020). Amgen is the best-selling drug company with the ability
to overcome barrier such as FDA approval which lead the company in top position. Thus, the
production, lifecycle and revenue would be at the top in the market, and the investors would
be benefited.